相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lysine catabolism reprograms tumour immunity through histone crotonylation
Huairui Yuan et al.
NATURE (2023)
Liver Colonization by Colorectal Cancer Metastases Requires YAP-Controlled Plasticity at the Micrometastatic Stage
Maria C. Heinz et al.
CANCER RESEARCH (2022)
Mutant KRAS regulates transposable element RNA and innate immunity via KRAB zinc-finger genes
Roman E. Reggiardo et al.
CELL REPORTS (2022)
Low expression of the metabolism-related gene SLC25A21 predicts unfavourable prognosis in patients with acute myeloid leukaemia
Wenjun Wang et al.
FRONTIERS IN GENETICS (2022)
The role of ROS in tumour development and progression
Eric C. Cheung et al.
NATURE REVIEWS CANCER (2022)
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer
Arafath K. Najumudeen et al.
NATURE GENETICS (2021)
Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer
Suhu Liu et al.
MOLECULAR CANCER RESEARCH (2021)
Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation
Peng Yuan et al.
CELL DEATH & DISEASE (2021)
Emerging roles of the solute carrier family in pancreatic cancer
Zijian Wu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism
Yong Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Targeting Krasg12c-mutant cancer with a mutation-specific inhibitor
J. G. Christensen et al.
JOURNAL OF INTERNAL MEDICINE (2020)
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance
Chi Chun Wong et al.
GASTROENTEROLOGY (2020)
KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth
Susanna Raho et al.
NATURE METABOLISM (2020)
SATB2-AS1 Suppresses Colorectal Carcinoma Aggressiveness by Inhibiting SATB2-Dependent Snail Transcription and Epithelial-Mesenchymal Transition
Yi-Qing Wang et al.
CANCER RESEARCH (2019)
Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin 3 transcriptional activating and MAPK/AKT signalling
Min-Hui Yang et al.
MOLECULAR CANCER (2019)
Cytosine-Based TET Enzyme Inhibitors
Gabriella N. L. Chua et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Connections between metabolism and epigenetics in cancers
Chitra Thakur et al.
SEMINARS IN CANCER BIOLOGY (2019)
Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy
Gang Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Mitochondrial oxodicarboxylate carrier deficiency is associated with mitochondrial DNA depletion and spinal muscular atrophy-like disease
Veronika Boczonadi et al.
GENETICS IN MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate
Chi Chun Wong et al.
GASTROENTEROLOGY (2016)
Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells
Deven Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
Jonathan M. L. Ostrem et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
From Krebs to clinic: glutamine metabolism to cancer therapy (vol 16, pg 619, 2016)
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
The Physiological Basis and Nutritional Function of Alpha-ketoglutarate
Liuqin He et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
SLC transporters as therapeutic targets: emerging opportunities
Lawrence Lin et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Blocking anaplerotic entry of glutamine into the TCA cycle sensitizes K-Ras mutant cancer cells to cytotoxic drugs
M. Saqcena et al.
ONCOGENE (2015)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The Endogenous Tryptophan Metabolite and NAD+ Precursor Quinolinic Acid Confers Resistance of Gliomas to Oxidative Stress
Felix Sahm et al.
CANCER RESEARCH (2013)
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Christopher T. Hensley et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors
Mengtao Xiao et al.
GENES & DEVELOPMENT (2012)
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Sandra Misale et al.
NATURE (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
Daniela Gaglio et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Jian-Bin Wang et al.
CANCER CELL (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids
Lakshminarayan M. Iyer et al.
CELL CYCLE (2009)
Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer
Shuang Wang et al.
JOURNAL OF PATHOLOGY (2009)
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer
Jens Neumann et al.
PATHOLOGY RESEARCH AND PRACTICE (2009)
Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, Mirror image polydactyly 1, in nasopharyngeal carcinoma
Arthur Kwok Leung Cheung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab
Minaxi Jhawer et al.
CANCER RESEARCH (2008)
Urgent need for a new staging system in advanced colorectal cancer
Graeme J. Poston et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Ras oncogenes: split personalities
Antoine E. Karnoub et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer
D Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Identification of the human mitochondrial oxodicarboxylate carrier - Bacterial expression, reconstitution functional characterization, tissue distribution, and chromosomal location
G Fiermonte et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
